Patent: 9,433,646
✉ Email this page to a colleague
Summary for Patent: 9,433,646
| Title: | Methods of inhibiting growth of a neoplastic cell |
| Abstract: | Disclosed are methods of preparing and using placentally-derived stem cells and compositions useful for the treatment of cancer. Said stem cells and compositions function through inducing a \"guided differentiation\" program in cancer cells, thereby reducing malignancy. Further extension of the invention pertains to augmenting ability of administered cells to induce differentiation through the co-administration of known differentiation inducing agents. Within the context of this disclosure, methods for inducing host responses to cancer are also described. |
| Inventor(s): | Ichim; Thomas E. (San Diego, CA) |
| Assignee: | XON CELLS, INC. (Germantown, MD) |
| Application Number: | 13/688,864 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,433,646
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Smith & Nephew, Inc. | SANTYL | collagenase | Ointment | 101995 | 06/04/1965 | ⤷ Try a Trial | 2025-07-14 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
